Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
16.21
0.25 (1.57%)
At close: Oct 09, 2025, 10:58 AM
1.57% (1D)
| Bid | 16.16 |
| Market Cap | 658.38M |
| Revenue (ttm) | 232.84M |
| Net Income (ttm) | 18.77M |
| EPS (ttm) | 0.32 |
| PE Ratio (ttm) | 50.66 |
| Forward PE | -3.56 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 16.28 |
| Volume | 120,058 |
| Avg. Volume (20D) | 469,636.8 |
| Open | 15.90 |
| Previous Close | 15.96 |
| Day's Range | 15.90 - 16.30 |
| 52-Week Range | 9.12 - 72.37 |
| Beta | 0.97 |
| Ex-Dividend Date | n/a |
About KROS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KROS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KROS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsKeros Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-7.29%
Keros Therapeutics shares are trading lower follow...
Unlock content with
Pro Subscription
6 months ago
+18.49%
Keros Therapeutics shares are trading higher. The company announced that its board has initiated a formal review process to evaluate strategic alternatives to maximize shareholder value.
